Glyat-KO Mouse
一般名
Glyat-KO
製品ID
S-KO-00490
背景情報
C57BL/6JCya
系統ID
KOCMP-107146-Glyat-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Glyat-KO Mouse（カタログ番号S-KO-00490）はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Glyat-KO
系統ID
KOCMP-107146-Glyat-B6J-VA
遺伝子名
製品ID
S-KO-00490
遺伝子別名
CAT, GAT, ACGNAT, A330009E03Rik
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conventional knockout
染色体
Chr 19
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000044976
NCBIトランスクリプトID
NM_145935.3
ターゲット領域
Exon 3~4
有効領域の大きさ
~2.8 kb
遺伝子研究の概要
GLYAT, or glycine N-acyltransferase, is an enzyme that catalyzes the transfer of acyl groups from acyl CoA to glycine, resulting in acyl glycine and coenzyme A. It is a key component of the phase II glycine conjugation pathway in the liver, playing a role in the detoxification of endogenous and xenobiotic compounds containing a carboxylic acid group, and is important for maintaining adequate levels of free coenzyme A (CoASH) [4,5,6,7].
GLYAT has been found to be lowly expressed in several cancers, including liver cancer, clear cell renal cell carcinoma (ccRCC), and breast cancer. In liver cancer and ccRCC, overexpression of GLYAT inhibits cell proliferation and migration, while interfering with GLYAT expression rescues these abilities. It was also shown to downregulate Rho-associated coiled-coil-containing protein kinase 1 (ROCK1), suggesting that GLYAT suppresses the progression of these cancers by downregulating ROCK1 [1]. In breast cancer, knockdown of GLYAT augmented cell proliferation in vitro and in vivo, and its downregulation promoted cell migration likely through the activation of the PI3K/AKT/Snail signaling pathway, which induced epithelial-mesenchymal transition (EMT) [3].
In conclusion, GLYAT is important in metabolic detoxification pathways. Its downregulation in various cancers has been associated with tumor progression, highlighting its potential as a prognostic biomarker and therapeutic target. The functional studies in cancer cell lines and in vivo models have provided insights into its role in cancer development, suggesting that understanding GLYAT could offer new strategies for cancer treatment [1,2,3,8].
References:
1. Xia, Yechen, Huang, Wentao, Jin, Guang-Zhi. 2024. GLYAT suppresses liver cancer and clear cell renal cell carcinoma progression by downregulating ROCK1 expression. In Translational cancer research, 13, 5097-5111. doi:10.21037/tcr-24-1412. https://pubmed.ncbi.nlm.nih.gov/39430840/
2. Jiang, Fengchen, Zhou, Shuiping, Xia, Chuanlong, Dai, Feng, Fu, Shouzhong. . Downregulation of GLYAT correlates with tumour progression and poor prognosis in hepatocellular carcinoma. In Journal of cellular and molecular medicine, 28, e70197. doi:10.1111/jcmm.70197. https://pubmed.ncbi.nlm.nih.gov/39495775/
3. Tian, Xin, Wu, Lina, Jiang, Min, Liu, Caigang, Gao, Song. 2021. Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer. In Frontiers in oncology, 11, 641399. doi:10.3389/fonc.2021.641399. https://pubmed.ncbi.nlm.nih.gov/33968740/
4. Kühn, Stefan, Williams, Monray E, Dercksen, Marli, Sass, Jörn Oliver, van der Sluis, Rencia. 2023. The glycine N-acyltransferases, GLYAT and GLYATL1, contribute to the detoxification of isovaleryl-CoA - an in-silico and in vitro validation. In Computational and structural biotechnology journal, 21, 1236-1248. doi:10.1016/j.csbj.2023.01.041. https://pubmed.ncbi.nlm.nih.gov/36817957/
5. Schulke, Daniel, Sass, Jörn Oliver. 2021. Frequent sequence variants of human glycine N-acyltransferase (GLYAT) and inborn errors of metabolism. In Biochimie, 183, 30-34. doi:10.1016/j.biochi.2021.02.002. https://pubmed.ncbi.nlm.nih.gov/33567294/
6. Lino Cardenas, Christian Lacks, Bourgine, Joanna, Cauffiez, Christelle, Broly, Frank, Chevalier, Dany. 2010. Genetic polymorphisms of glycine N-acyltransferase (GLYAT) in a French Caucasian population. In Xenobiotica; the fate of foreign compounds in biological systems, 40, 853-61. doi:10.3109/00498254.2010.519407. https://pubmed.ncbi.nlm.nih.gov/20925583/
7. Badenhorst, Christoffel Petrus Stephanus, van der Sluis, Rencia, Erasmus, Elardus, van Dijk, Alberdina Aike. 2013. Glycine conjugation: importance in metabolism, the role of glycine N-acyltransferase, and factors that influence interindividual variation. In Expert opinion on drug metabolism & toxicology, 9, 1139-53. doi:10.1517/17425255.2013.796929. https://pubmed.ncbi.nlm.nih.gov/23650932/
8. Muñoz, Juan P, Calaf, Gloria M. 2023. Downregulation of Glycine N-Acyltransferase in Kidney Renal Clear Cell Carcinoma: A Bioinformatic-Based Screening. In Diagnostics (Basel, Switzerland), 13, . doi:10.3390/diagnostics13233505. https://pubmed.ncbi.nlm.nih.gov/38066746/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。